CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-10 | KLOSK STEVEN M Director | Grant or award | +65,430 | 151,390 | ||
| 2022-01-10 | MYERS STEVEN S Director | Grant or award | +65,430 | 212,269 | ||
| 2021-12-08 | MYERS STEVEN S Director | Purchase | +33,785 | $0.89 | $30K | 146,839 |
| 2021-09-01 | Buck Kristen K EVP, R&D and CMO | Grant or award | +312,500 | 312,500 | ||
| 2021-09-01 | Buck Kristen K EVP, R&D and CMO | Shares withheld for taxes | −50,103 | $1.28 | $64K | 262,397 |
| 2021-09-01 | Buck Kristen K EVP, R&D and CMO | Grant or award · Stock Option (Right to Buy) | +1,137,915 | 1,137,915 | ||
| 2021-01-14 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −5,936 | $1.56 | $9K | 299,505 |
| 2021-01-13 | Mazzo David J Chief Executive Officer | Grant or award | +39,000 | 333,653 | ||
| 2021-01-13 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −21,787 | $1.55 | $34K | 311,866 |
| 2021-01-13 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −6,425 | $1.55 | $10K | 305,441 |
| 2021-01-11 | Schwalm Cynthia Director | Grant or award | +37,735 | 80,417 | ||
| 2021-01-11 | Whitaker Anne Clem Director | Grant or award | +37,735 | 117,205 | ||
| 2021-01-11 | Davidson Michael H. Director | Grant or award | +37,735 | 144,323 | ||
| 2021-01-11 | BROWN GREGORY B Director | Grant or award | +37,735 | 83,610 | ||
| 2021-01-11 | Mazzo David J Chief Executive Officer | Grant or award | +119,000 | 311,274 | ||
| 2021-01-11 | Mazzo David J Chief Executive Officer | Shares withheld for taxes | −16,621 | $1.59 | $26K | 294,653 |
| 2021-01-11 | Mazzo David J Chief Executive Officer | Grant or award · Stock Options (Right to Buy) | +60,000 | 60,000 | ||
| 2021-01-11 | TRABER PETER G Director | Grant or award | +37,735 | 83,760 | ||
| 2021-01-11 | KLOSK STEVEN M Director | Grant or award | +37,735 | 85,960 | ||
| 2021-01-11 | MYERS STEVEN S Director | Grant or award | +37,735 | 113,054 |
Page 7 of 18 · 345 trades